Inventor
LANNFELT LARS
SE17 patents
⚠️ This page may combine multiple inventors who share the name “LANNFELT LARS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOARCTIC NEUROSCIENCE AB
8 patentsUS8025878B2Sep 27, 2011
Protofibril selective antibodies and the use thereof
BIOARCTIC NEUROSCIENCE AB49 citations92
US9084832B2Jul 21, 2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
BIOARCTIC NEUROSCIENCE AB13 citations89
US8859501B2Oct 14, 2014
Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
BIOARCTIC NEUROSCIENCE AB13 citations89
US9315569B2Apr 19, 2016
Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
BIOARCTIC NEUROSCIENCE AB7 citations80
US8968734B2Mar 3, 2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
BIOARCTIC NEUROSCIENCE AB9 citations80
US7700719B2Apr 20, 2010
Arctic β amyloid protofibril
BIOARCTIC NEUROSCIENCE AB10 citations80
US8999936B2Apr 7, 2015
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
BIOARCTIC NEUROSCIENCE AB2 citations60
US7709695B1May 4, 2010
Transgenic mouse expressing arctic mutation E693G
BIOARCTIC NEUROSCIENCE AB4 citations60
LANNFELT LARS
3 patentsUS7179463B2Feb 20, 2007
Treatment of alzheimer's disease
LANNFELT LARS55 citations91
US8409575B2Apr 2, 2013
Antibodies specific for amyloid beta protofibril
LANNFELT LARS12 citations88
US8809506B2Aug 19, 2014
Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
LANNFELT LARS11 citations79